Jefferies Raises Estimates on Pfizer (PFE); Positive on Eliquis and Xeljanz Launches
Tweet Send to a Friend
Jefferies raised estiamtes by reiterated a Buy rating and $31 price target on Pfizer (NYSE: PFE) saying the Eliquis and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
